According to data from the American Cancer Society, cancer was predicted to be the cause of nearly 609 820 US fatalities in 2023 which is about 1670 deaths per day.1 Vascular endothelial growth factor receptor 2 (VEGFR2) has been identified as a key target for anticancer therapy. The gene discussed is KDR; the disease is cancer.